Danlion Pharmaceuticals Private Limited - Company Profile

It is a service private limited company based in Fursungi, Maharashtra, India, established in 2017.
2017 Fursungi, Maharashtra, India Active
Last Updated:
Access Report
About Danlion Pharmaceuticals Private Limited

Danlion Pharmaceuticals Private Limited, a active private limited company, was established on 05 July 2017 in Fursungi, Maharashtra, India. Engaging in other services within the service sector, it holds CIN: U93090PN2017PTC171285. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Satveek Hanumant Giramkar (Director), Premchand Ramchandra Bhusanar (Director), Jitendra Kalpnath Singh (Director). Past directors included Ketaki Vishal Satte. It holds ₹4.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Godown No 2 Ground Floor Milkat No 17660 Se.No 166/1/1 Fursungi, Fursungi, Maharashtra, 412308.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U93090PN2017PTC171285

  • Registration Number

    171285

  • Incorporation Date

    05 July 2017

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.50 M
  • Revenue Growth **** 68.98%
  • Profit Growth **** 130.46%
  • Ebitda **** 156.56%
  • Net Worth 37.52%
  • Total Assets **** 24.13%
Company report

Danlion Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Danlion Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Danlion Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Satveek Hanumant Giramkar Director 05 Jul 2017 Current
Premchand Ramchandra Bhusanar Director 05 Jul 2017 Current
Jitendra Kalpnath Singh Director 05 Jul 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Danlion Pharmaceuticals.

Danlion Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 68.98% increase. The company also saw a substantial improvement in profitability, with a 130.46% increase in profit. The company's net worth Soared by an impressive increase of 37.52%.

Danlion Pharmaceuticals revenue growth over time
Danlion Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 68.98%
*******
*******
*******
*******
Revenue from Operations
*******
 68.90%
*******
*******
*******
*******
Total Assets
*******
 24.13%
*******
*******
*******
*******
Profit or Loss
*******
 130.46%
*******
*******
*******
*******
Net Worth
*******
 37.52%
*******
*******
*******
*******
EBITDA
*******
 156.56%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Danlion Pharmaceuticals?

Unlock access to Danlion Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹4,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.45 Cr
Latest Charge Details
Date Lender Amount Status
27 Dec 2024 Others ₹4.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Danlion Pharmaceuticals?

Unlock and access historical data on people associated with Danlion Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Danlion Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Danlion Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Danlion Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Danlion Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Danlion Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was completed.

  • Charges

    A charge with Others amounted to Rs. 4.50 M with Charge ID 101027294 was registered on 27 Dec 2024. was recorded as a recent event.

  • Director Appointment

    Progress on Satveek Hanumant Giramkar was appointed as a Director was appointed as a Director on 05 Jul 2017 & has been associated with this company since 8 years 7 months . was documented.

  • Director Appointment

    Progress on Premchand Ramchandra Bhusanar was appointed as a Director was appointed as a Director on 05 Jul 2017 & has been associated with this company since 8 years 7 months . was documented.

  • Director Appointment

    Progress on Jitendra Kalpnath Singh was appointed as a Director was appointed as a Director on 05 Jul 2017 & has been associated with this company since 8 years 7 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Danlion Pharmaceuticals Private Limited?

The CIN of Danlion Pharmaceuticals Private Limited is U93090PN2017PTC171285.

Where is Danlion Pharmaceuticals Private Limited headquartered?

Danlion Pharmaceuticals Private Limited is headquartered at Godown No 2 Ground Floor Milkat No 17660 Se.No 166/1/1 Fursungi, Fursungi, Maharashtra, 412308.

When was Danlion Pharmaceuticals Private Limited incorporated?

Danlion Pharmaceuticals Private Limited was incorporated on 05 July 2017.

Who are the current directors of Danlion Pharmaceuticals Private Limited?

The current directors of Danlion Pharmaceuticals Private Limited are

What is the primary industry of Danlion Pharmaceuticals Private Limited?

The primary industry of Danlion Pharmaceuticals Private Limited is Service.

Is Danlion Pharmaceuticals Private Limited a listed company?

Danlion Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Danlion Pharmaceuticals Private Limited?

The authorized capital of Danlion Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Danlion Pharmaceuticals Private Limited?

The compliance status of Danlion Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available